The global tea extracts market is estimated to be valued at USD 2.5 billion in 2019 and is projected to reach USD 3.8 billion by 2025, recording a CAGR of 6.9%. The market is projected to witness significant growth due to factors such as the increase in the consumption of functional foods, rise in health consciousness among consumers, and increasing adoption of tea due to the ill-effects from caffeine, thereby widening the scope of its applications. The increasing market potential, growing population, and growing demand for different types of tea extracts, as per health benefits, are factors that are projected to impact the growth of the tea extracts market.
Download PDF brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102874765
By application, the food segment is projected to witness the highest growth in tea extracts market during the forecast period.
There has been an increasing adoption of botanical extracts, as functional or flavor ingredients, in the food industry. Ingredient manufacturers, such as ADM and Givaudan, have been innovating the application of tea flavors in food products, such as bakery and confectionery products, frozen desserts, and dairy products. Also, the familiarity of this flavor among consumers have been driving the demand for tea-based foods, and hence, the segment has been projected to grow at a comparatively higher growth rate during the forecast period.
By type, the green tea segment is projected to dominate the tea extracts market during the forecast period.
Green tea has already gained traction across the globe as a healthy alternative for caffeinated drinks. Its antioxidant property, complemented with its anti-inflammatory characteristics, has made tea extracts one of the most preferred beverages for consumers. An increase in the consumption of premium foods and increase in the popularity of functional foods also boost the opportunity for market. Innovative applications of green tea extract in cosmetics application has also expanded the growth opportunities in the market.
The increasing demand for tea extracts in Asia Pacific is projected to drive the growth of the market.
Though, a major producer of tea, consumption of tea-based RTD beverages and nutraceutical products are still in the nascent stages among Asian countries. Consumers, majorly favor tea as a hot beverage and not as a convenient product. Thus, the market for Asia Pacific in tea extract consumption is smaller compared to the North American and European markets. In addition, the market for tea extracts is fragmented in the Asia Pacific region, with multiple emerging and small-scale companies developing generic tea extracts in the Chinese market. The increase in FDI and increase in the living standards are going to make countries like China, India, Malaysia, and Thailand a promising opportunity for tea extracts market.
Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=102874765
Key Market Players
Key players in this market include Archer Daniels Midland (US), Dupont (US), Kemin Industries (US), Givaudan (Switzerland), Synthite Industries Ltd. (India), Synergy Flavors (US), Frutarom (US), Finlays (UK), A.Holliday & Co. (Canada), Martin Bauer Group (Germany), Indena SPA (Italy), Futureceuticals (US), Amax Nutrasource Inc. (US), Cymbio Pharma Pvt. Ltd. (India), Teawolf (US), Phyto Life Sciences Pvt Ltd. (India), Taiyo International (Japan), AVT Tea Sources Ltd. (India), Halssen & Lyon GMBH (Germany), and Harrisons Tea (India). Major players in this market are focusing on enhancing their presence through new product launches, expansions, mergers & acquisitions, and collaborations. These companies have a strong presence in North America and Europe. They also have their manufacturing facilities and strong distribution networks across these regions.
According to the new market research report “ Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023", published by MarketsandMarkets™,The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.Access Free Sample Research Copy : https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137Growth in the particle therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.Synchrotrons are used to accelerate both protons and heavy ions such as carbon and hydrogen.
The growth of the synchrotrons segment is attributed to factors such as the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.Report Objectives :1.
To define, describe, and forecast the global particle therapy market on the basis of type, product & service, cancer type, system, application, and region2.
To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global particle therapy market3.
To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global particle therapy market4.
To analyze the opportunities in the global particle therapy market for key stakeholders and provide details of the competitive landscape for market leadersDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137By application, treatment applications are expected to be the largest contributor to the particle therapy marketThe introduction of small footprint single-room particle therapy centers is further promoting the adoption of proton therapy for the treatment of cancer in small-scale hospitals.
The report "EMEA 3D CBCT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) - Forecast to 2023", The EMEA 3D CBCT systems market is expected to reach USD 300.4 Million by 2023 from an estimated USD 194.3 Million in 2018, at a CAGR of 9.0%.
Increasing disposable incomes, rising healthcare expenditure, and the availability of health insurance, the willingness to undergo expensive cosmetic procedures in various countries has increased.
Moreover, the rising expenditure on treatments for appearance enhancements is driving the demand for dental products in the market.Browse 74 market data Tables and 17 Figures spread through 115 Pages and in-depth TOC on "EMEA 3D CBCT/Cone Beam CT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) - Forecast to 2023"Get Free PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148086734By application, the dental segment accounted for the largest share of the EMEA 3D CBCT systems market in 2017The market is broadly segmented into dental and non-dental applications.
The dental applications segment further subsegmented into implantology, oral and maxillofacial surgery, orthodontics, endodontics, and other dental applications.
The non-dental applications segment is subsegmented into ENT and radiology.
The dental application segment accounted for the largest share of EMEA 3D CBCT systems market in 2017.
The demand for smaller, fast, and more reliable devices has led to the demand for wide bandgap (WBG) semiconductors globally.
WBG semiconductors have huge potential to meet the performance demands in the emerging equipment and devices.
These semiconductors enable operations at higher voltages and temperature ranges and provide Sample switching frequencies with greater efficiencies compared with the existing silicon-based devices.
WBG material devices offer a comparatively smaller footprint than the traditional silicon materials.Gallium oxide is one of the emerging WBG materials, which is exponentially expediting in the semiconductor market.
The critical factors of gallium oxide materials that are responsible for its adoption in the market are reliability, compact size, high efficiency, fast switching speed, and temperature range, among others.
The gallium oxide material overshadows the performance of Si materials driven by factors such as the reduction in energy losses, the ability to deal with high voltage operations, high operating frequency, and high-power density.
